Arun Sharma, Stephen M. Schwartz and Eduardo Méndez Hospital volume is associated with survival but not multimodality therapy in Medicare patients with advanced head and neck cancer Cancer 119
Version of Record online: 1 MAR 2013 | DOI: 10.1002/cncr.27976
Patients with advanced head and neck squamous cell carcinoma treated at high-volume hospitals had better survival, but were not more likely to receive National Comprehensive Cancer Network (NCCN) guideline therapy, when compared with patients treated at low-volume hospitals. These results suggest that features of high-volume hospitals, other than delivery of NCCN guideline therapy, influence survival.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field